Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2014: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2013: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2012: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Outline of Final Research Achievements |
We aimed to optimize the method for generation of chimeric antigen receptor-gene modified T lymphocyte (CD19CAR-T). For the generation of allogeneic CD19CAR-T lymphocytes, we analyzed the method for better generation of virus-specific/ CD19CAR-gene modified T lymphocytes. We tested the possible combination of cytokine combination and concentration. As a result, the IL-2 and IL-21 combination was better than other conditions. For the optimization of autologous CD19CAR-T lymphocytes, we developed drug-inducible expression system of CD19CAR, and demonstrated that we could successfully control CD19CAR expression under drug administration.
|